
Sarah Alawadi
Examiner (ID: 2974, Phone: (571)270-7678 , Office: P/1619 )
| Most Active Art Unit | 1619 |
| Art Unit(s) | 1619 |
| Total Applications | 802 |
| Issued Applications | 269 |
| Pending Applications | 127 |
| Abandoned Applications | 450 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18953390
[patent_doc_number] => 20240041717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => DISINFECTING, SKIN-TOLERABLE, SUPERFATTING CARE AGENT FOR APPLICATION TO THE SKIN
[patent_app_type] => utility
[patent_app_number] => 18/017296
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017296
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017296 | DISINFECTING, SKIN-TOLERABLE, SUPERFATTING CARE AGENT FOR APPLICATION TO THE SKIN | Jul 7, 2021 | Pending |
Array
(
[id] => 18536071
[patent_doc_number] => 20230241158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => Hydrophilic Degradable Microspheres for Local Delivering of Glycopeptide Antibiotics and Polycationic Peptide Antibiotics
[patent_app_type] => utility
[patent_app_number] => 18/003174
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16221
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18003174
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/003174 | Hydrophilic Degradable Microspheres for Local Delivering of Glycopeptide Antibiotics and Polycationic Peptide Antibiotics | Jul 6, 2021 | Abandoned |
Array
(
[id] => 17168720
[patent_doc_number] => 20210322390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => SPHINGOSINE KINASE 2 INHIBITOR FOR TREATING CORONAVIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/364386
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16222
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17364386
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/364386 | SPHINGOSINE KINASE 2 INHIBITOR FOR TREATING CORONAVIRUS INFECTION | Jun 29, 2021 | Pending |
Array
(
[id] => 18565541
[patent_doc_number] => 20230255868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => SANITIZING COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/011655
[patent_app_country] => US
[patent_app_date] => 2021-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8159
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011655
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/011655 | SANITIZING COMPOSITION | Jun 27, 2021 | Pending |
Array
(
[id] => 18595864
[patent_doc_number] => 20230270653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => USE OF TREHALOSE FOR INHIBITING AILMENT INDUCING MICROORGANISMS
[patent_app_type] => utility
[patent_app_number] => 18/014382
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5537
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014382
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/014382 | USE OF TREHALOSE FOR INHIBITING AILMENT INDUCING MICROORGANISMS | Jun 10, 2021 | Pending |
Array
(
[id] => 18595864
[patent_doc_number] => 20230270653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => USE OF TREHALOSE FOR INHIBITING AILMENT INDUCING MICROORGANISMS
[patent_app_type] => utility
[patent_app_number] => 18/014382
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5537
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014382
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/014382 | USE OF TREHALOSE FOR INHIBITING AILMENT INDUCING MICROORGANISMS | Jun 10, 2021 | Pending |
Array
(
[id] => 18860223
[patent_doc_number] => 20230414657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => Novel compositions for neutralizing toxic effects of hydrogen peroxide in living cells or tissues
[patent_app_type] => utility
[patent_app_number] => 18/033383
[patent_app_country] => US
[patent_app_date] => 2021-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15832
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18033383
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/033383 | Novel compositions for neutralizing toxic effects of hydrogen peroxide in living cells or tissues | Jun 6, 2021 | Pending |
Array
(
[id] => 18860223
[patent_doc_number] => 20230414657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => Novel compositions for neutralizing toxic effects of hydrogen peroxide in living cells or tissues
[patent_app_type] => utility
[patent_app_number] => 18/033383
[patent_app_country] => US
[patent_app_date] => 2021-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15832
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18033383
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/033383 | Novel compositions for neutralizing toxic effects of hydrogen peroxide in living cells or tissues | Jun 6, 2021 | Pending |
Array
(
[id] => 17241931
[patent_doc_number] => 20210361674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => Treating Auto-Immune and Auto-Inflammatory Diseases
[patent_app_type] => utility
[patent_app_number] => 17/240698
[patent_app_country] => US
[patent_app_date] => 2021-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8785
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17240698
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/240698 | Treating Auto-Immune and Auto-Inflammatory Diseases | Apr 25, 2021 | Pending |
Array
(
[id] => 17109954
[patent_doc_number] => 20210290551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => DRUG DELIVERY SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/223124
[patent_app_country] => US
[patent_app_date] => 2021-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17223124
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/223124 | DRUG DELIVERY SYSTEM | Apr 5, 2021 | Abandoned |
Array
(
[id] => 16961464
[patent_doc_number] => 20210212963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => METHODS OF ADMINISTERING ANIONIC CANNABINOIDS DISSOLVED IN WATER
[patent_app_type] => utility
[patent_app_number] => 17/216341
[patent_app_country] => US
[patent_app_date] => 2021-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8616
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17216341
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/216341 | METHODS OF ADMINISTERING ANIONIC CANNABINOIDS DISSOLVED IN WATER | Mar 28, 2021 | Abandoned |
Array
(
[id] => 17080491
[patent_doc_number] => 20210275497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => MACROGOL 15 HYDROXYSTEARATE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/203429
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65907
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17203429
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/203429 | MACROGOL 15 HYDROXYSTEARATE FORMULATIONS | Mar 15, 2021 | Abandoned |
Array
(
[id] => 17213089
[patent_doc_number] => 20210346425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => BOTANICAL FILM-FORMING ACNE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/178692
[patent_app_country] => US
[patent_app_date] => 2021-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11185
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178692
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/178692 | BOTANICAL FILM-FORMING ACNE COMPOSITIONS | Feb 17, 2021 | Abandoned |
Array
(
[id] => 18255929
[patent_doc_number] => 20230082968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => EXOGENOUS NITRIC OXIDE FOR IMPROVED SUSCEPTIBILITY AND LOWERED ANTIBIOTIC RESISTANCE IN RESISTANT RESPIRATORY BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/799871
[patent_app_country] => US
[patent_app_date] => 2021-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9340
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17799871
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/799871 | EXOGENOUS NITRIC OXIDE FOR IMPROVED SUSCEPTIBILITY AND LOWERED ANTIBIOTIC RESISTANCE IN RESISTANT RESPIRATORY BACTERIA | Feb 10, 2021 | Pending |
Array
(
[id] => 18255929
[patent_doc_number] => 20230082968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => EXOGENOUS NITRIC OXIDE FOR IMPROVED SUSCEPTIBILITY AND LOWERED ANTIBIOTIC RESISTANCE IN RESISTANT RESPIRATORY BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/799871
[patent_app_country] => US
[patent_app_date] => 2021-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9340
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17799871
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/799871 | EXOGENOUS NITRIC OXIDE FOR IMPROVED SUSCEPTIBILITY AND LOWERED ANTIBIOTIC RESISTANCE IN RESISTANT RESPIRATORY BACTERIA | Feb 10, 2021 | Pending |
Array
(
[id] => 18265288
[patent_doc_number] => 20230086530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => HUMAN CD47-TARGETING SINGLE-DOMAIN ANTIBODY AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/799543
[patent_app_country] => US
[patent_app_date] => 2021-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18905
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17799543
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/799543 | Human CD47-targeting single-domain antibody and use thereof | Feb 9, 2021 | Issued |
Array
(
[id] => 16883604
[patent_doc_number] => 20210169799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => COMPOSITION AND METHOD FOR VANCOMYCIN ORAL LIQUID
[patent_app_type] => utility
[patent_app_number] => 17/165754
[patent_app_country] => US
[patent_app_date] => 2021-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17131
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17165754
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/165754 | COMPOSITION AND METHOD FOR VANCOMYCIN ORAL LIQUID | Feb 1, 2021 | Abandoned |
Array
(
[id] => 17349954
[patent_doc_number] => 11224572
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-01-18
[patent_title] => Stable oral liquid composition of terazosin
[patent_app_type] => utility
[patent_app_number] => 17/163848
[patent_app_country] => US
[patent_app_date] => 2021-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4972
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17163848
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/163848 | Stable oral liquid composition of terazosin | Jan 31, 2021 | Issued |
Array
(
[id] => 18197069
[patent_doc_number] => 20230050588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => ANTIOXIDANT OR SKIN STRESS INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/796584
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4115
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796584
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/796584 | ANTIOXIDANT OR SKIN STRESS INHIBITOR | Jan 28, 2021 | Pending |
Array
(
[id] => 19736685
[patent_doc_number] => 12213485
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-04
[patent_title] => Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
[patent_app_type] => utility
[patent_app_number] => 17/146662
[patent_app_country] => US
[patent_app_date] => 2021-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9627
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17146662
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/146662 | Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops | Jan 11, 2021 | Issued |